Related Experiment Video
Updated: Feb 27, 2026

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
Published on: June 25, 2018
The protective effect of Ginsenoside Rg1 on aging mouse pancreas damage induced by D-galactose
Zhaoying Dong1, Mengxiong Xu2, Jie Huang2
1Chongqing Medical University, Affiliated First Clinical College, Yuzhong, Chongqing 400016, P.R. China.
Abstract:
The protective effect and mechanism of Ginsenoside Rg1 on aging mouse pancreas damaged by D-galactose (D-gal)-induced was studied. Two-month-old male C57BL/6J mice were randomly divided into three groups of 10 mice per group. The D-gal group of mice received hypodermic injection of D-gal (120 mg/kg/day) for 42 days; the Rg1+D-gal group of mice receiving D-gal + intraperitoneal injection Rg1 (40 mg/kg/day) for 27 days from the 16th day of D-gal replication; and the naïve group that constituted the normal control mice receiving the same dose of saline instead of the drug. The related indicators were tested on the second day after modeling and administration. Fasting blood glucose (FBG), oral glucose tolerance test (OGTT) and fasting insulin level were measured by taking peripheral blood. Samples of pancreas were weighed and visceral index was calculated. Paraffin sections were prepared. H&E staining sections were produced to observe pancreatic tissue morphology. Immunohistochemical staining was used to observe advanced glycation end products (AGEs) and integral optical density (IOD) of stained positive tissue in pancreas. Ultrathin slices were used to observe ultrastructural change of pancreatic tissue. Frozen sections were prepared to test the relative optical density of positive cells that were stained by senescence-associated β-galactosidase (SA-β-gal) in pancreatic tissue. Superoxide dismutase (SOD), malonaldehyde (MDA) and total antioxidant capacity (T-AOC) were detected by preparing pancreas tissue homogenates. Compared with the control group, Rg1+D-gal mice had significantly decreased pancreatic wet weight and visceral index and significantly lower FBG; OGTT for 30 and 120 min. There was no significant difference of the blood sugar level between the groups. The area under the curve and the number and size of the nucleated cells within islet were markedly reduced. In addition, SA-β-gal-positive particles in pancreas tissue intracytoplasmic cells significantly decreased and relative optical density also reduced. The IOD of AGEs in pancreas tissue and MDA content decreased. SOD and T-AOC activity significantly increased. Ginsenoside Rg1 can be effective antagonistic structure and function of the pancreas injury induced by D-gal. The mechanism may be associated with reducing oxidative damage.
Insights
Ginsenoside Rg1 protects the aging mouse pancreas from D-galactose-induced damage by reducing oxidative stress. This study reveals Rg1
Area of Science:
- Gerontology
- Pharmacology
- Biochemistry
Background:
- Aging is associated with pancreatic dysfunction.
- D-galactose (D-gal) induces aging-like changes and pancreatic damage in mice.
- Ginsenoside Rg1 is a potential therapeutic agent.
Purpose of the Study:
- To investigate the protective effects of Ginsenoside Rg1 against D-gal-induced pancreatic aging.
- To elucidate the underlying mechanisms of Rg1's protective action.
Main Methods:
- D-galactose induction of pancreatic aging in C57BL/6J mice.
- Treatment with Ginsenoside Rg1.
- Assessment of pancreatic morphology, glucose metabolism, oxidative stress markers (SOD, MDA, T-AOC), advanced glycation end products (AGEs), and senescence-associated β-galactosidase (SA-β-gal).
Main Results:
- Rg1 treatment significantly reduced pancreatic wet weight, visceral index, and fasting blood glucose.
- Rg1 mitigated D-gal-induced declines in islet cell number and size.
- Rg1 decreased oxidative stress, AGEs, and SA-β-gal expression, while increasing antioxidant capacity.
Conclusions:
- Ginsenoside Rg1 exhibits protective effects against D-galactose-induced pancreatic injury in aging mice.
- The mechanism involves the reduction of oxidative damage and cellular senescence.
- Rg1 holds potential for mitigating age-related pancreatic dysfunction.
More Related Videos
07:44Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024